XLENCE PHARMA

Braine-l'Alleud ·KBO/BCE: BE 0792.642.824

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	76.9%	55.3%	better than 72% of 4691 sector peers
Net result	€7k	€38k	better than 22% of 4690 sector peers
Equity	€65k	€64k	better than 50% of 4691 sector peers
Gross operating margin	€14k	€61k	better than 18% of 4683 sector peers
Total assets	€84k	€145k	better than 29% of 4691 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€84k
Fixed assets	21/28	€23k
Intangible fixed assets	21	€20k
Tangible fixed assets	22/27	€3k
Financial fixed assets	28	€86
Current assets	29/58	€61k
Amounts receivable within one year	40/41	€12k
Cash & bank	54/58	€45k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€84k
Equity	10/15	€65k
Contributions / capital	10/11	€5k
Accumulated profits (losses)	14	€60k
Amounts payable	17/49	€19k
Amounts payable within one year	42/48	€19k
Trade debts payable within one year	44	€4k
Income statement
Gross operating margin	9900	€14k
Operating result	9901	€9k
Financial income	75	€729
Financial charges	65	€2k
Result before taxes	9903	€8k
Income taxes	67/77	€731
Net result for the period	9904	€7k
Result to be appropriated	9905	€7k

Summary